Business Description
Akeso Inc. is a China-based biopharmaceutical company founded in 2012 that creates and sells antibody-based medicines for patients around the world. Its pipeline spans a wide range of serious conditions, including multiple forms of cancer such as lung, cervical, gastric, and liver cancer, as well as skin and blood disorders like psoriasis and leukemia. The company has several treatments already on the market and many more in active development, with a particular focus on next-generation bi-specific antibodies that target two disease pathways at once.